0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Medicine and Public Policy |

A Framework for Management of Hepatitis C in Prisons

Anne C. Spaulding, MD, MPH; Cindy M. Weinbaum, MD, MPH; Daryl T.-Y. Lau, MD, MPH; Richard Sterling, MD; Leonard B. Seeff, MD; Harold S. Margolis, MD; and Jay H. Hoofnagle, MD
[+] Article and Author Information

From Centers for Disease Control and Prevention, Atlanta, Georgia; University of Texas Medical Branch, Galveston, Texas; Virginia Commonwealth University Health System, Richmond, Virginia; and National Institutes of Health, Bethesda, Maryland.


Acknowledgments: The authors thank the following people for providing the planning group with the correctional professional viewpoint: James Gondles, American Correctional Association; Edward Harrison, National Commission on Correctional Health Care; Timothy Ryan, American Jail Association; and Richard Stalder, Association of State Correctional Administrators. The authors also thank Keith Bordelon, Centers for Disease Control and Prevention, and Samantha McCready and Carol Schagunn, University of Minnesota, for contributions to the coordination and planning of the January 2003 meeting in San Antonio, Texas.

Potential Financial Conflicts of Interest: Consultancies: D.T.-Y. Lau (Roche, GlaxoSmithKline, Bristol-Myers Squibb); Expert testimony: A.C. Spaulding (Dr. Spaulding has given expert testimony on prisoners' right to receive medical management of hepatitis C); Honoraria: D.T.-Y. Lau (Bristol-Myers Squibb, Roche, GlaxoSmithKline); Grants received: D.T.-Y. Lau (GlaxoSmithKline, Bristol-Myers Squibb, Roche), R. Sterling (Schering-Plough, Roche); Grants pending: R. Sterling (Roche, Schering-Plough).

Requests for Single Reprints: Anne C. Spaulding, MD, MPH, Rollins School of Public Health of Emory University, Department of Epidemiology, 1518 Clifton Road NE, Atlanta, GA 30322; e-mail, aspauld@emory.edu.

Current Author Addresses: Dr. Spaulding: Rollins School of Public Health of Emory University, Department of Epidemiology, 1518 Clifton Road NE, Atlanta, GA 30322.

Dr. Weinbaum: Centers for Disease Control and Prevention, 1500 Clifton Road MS G37, Atlanta, GA 30333.

Dr. Lau: University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555.

Dr. Sterling: Virginia Commonwealth University Health System, 1200 East Broad Street, Room 1454, Richmond, VA 23298.

Drs. Seeff and Hoofnagle: National Institutes of Health, 31 Center Drive, Bethesda, MD 20892.

Dr. Margolis: International Vaccine Institute, SNU Research Park, San 4-8 Bongeheon-7-dong, Seoul, Korea 151-818.


Ann Intern Med. 2006;144(10):762-769. doi:10.7326/0003-4819-144-10-200605160-00010
Text Size: A A A

The prevalence of chronic hepatitis C virus (HCV) infection in prisons ranges from 12% to 31%. There are generally accepted—albeit still evolving—guidelines for identification and treatment of hepatitis C in the community. However, there is less agreement among health professionals caring for prisoners about best practices for identification, medical management, and treatment of hepatitis C. Inmates often lack health care before incarceration. In prisons, infected persons could be identified and the management of infection initiated; however, the high prevalence of HCV infection among prisoners would impose a disproportionate cost for hepatitis C care on the correctional system. The optimal solution is for prison and public health systems in the United States to jointly provide targeted HCV testing and standard-of-care hepatitis C medical management, treatment, and prevention programs to prison inmate populations. The authors report on a January 2003 meeting of experts in prison health, public health, hepatology, and infectious diseases and explore the clinical care, prevention, and collaboration needed to provide hepatitis C management in prisoners.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)